Cite
HARVARD Citation
Gow, P. et al. (2022). Safety and efficacy of outpatient continuous terlipressin infusion for the treatment of portal hypertensive complications in cirrhosis. European journal of gastroenterology & hepatology. 34 (2), p. . [Online].